The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Cochrane Launches Journal Club with RA Article

Cochrane Launches Journal Club with RA Article

February 1, 2010 • By From the College

  • Tweet
  • Email
Print-Friendly Version / Save PDF

The Cochrane Library, known for its high-quality evidence-based reviews and other resources that physicians can use to inform their clinical decisions, launched an online journal club in October 2009—and the complex question of biologic use in rheumatoid arthritis (RA) was first the topic of discussion.

You Might Also Like
  • Anti-TNF Agents May Improve Clinical Symptoms of Ankylosing Spondylitis
  • The ACR Debuts Open Access Journal
  • Patient Fact Sheet: Juvenile Idiopathic Arthritis
Explore This Issue
February 2010
Also By This Author
  • UnitedHealthcare Delays Copay Accumulator Policy

The Cochrane Journal Club is a resource for physicians and researchers who currently participate in a journal club or who would like to start one at their institution. Each monthly issue examines a recently published Cochrane review, providing summaries and analysis of the review, together with a variety of multimedia resources—including PowerPoint discussion slides with relevant charts and tables and podcasts from the authors. The Cochrane Journal Club also provides discussion points and key critical questions to facilitate journal groups’ discussion of the review at a journal club meeting. Finally, the club Web site (www.cochranejournalclub.com) has an interactive component where visitors can ask the authors questions and view questions posed by other readers.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The pilot Cochrane Journal Club highlighted “Biologics for Rheumatoid Arthritis,” the first overview of reviews to be published in the Cochrane Library. Because the paper included both information to help rheumatologists make difficult clinical decisions and innovative methodological approaches to comparing treatments indirectly, the Journal Club discussed both the clinical and methodological aspects of the review.

“Biologics for Rheumatoid Arthritis” looked at six current Cochrane reviews on different biologic disease-modifying antirheumatic drugs (DMARDs), each assessing one DMARD compared with a placebo and including at least one randomized trial. The overview of Cochrane reviews provides a summary of the benefits and harms of each DMARD and also includes indirect comparisons between the drugs. (See “Summary of the Cochrane Review.”)

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Although the DMARDs reviewed did seem to improve symptoms and prevent joint deterioration, deciding which drug to prescribe a given patient still may be a challenge for rheumatologists. “Doctors are faced with a difficult dilemma when choosing biologics to prescribe to RA patients. Our Cochrane overview cannot identify the ‘best’ biologic for any individual patient,” said Jasvinder Singh, MD—lead author of the paper, a rheumatologist at the Minneapolis VA Medical Center, and associate professor of medicine at the University of Minnesota in Minneapolis—in the Journal Club podcast. “That choice needs to use other knowledge as well. Some of that knowledge is in the individual Cochrane reviews … and some of it will need to come through local information and discussion with the patients. For example, how much experience is there with a particular biologic in the clinical team and does the patient have preferences about the different ways in which the drugs need to be taken?”

Summary of the Cochrane Review

Singh JA, Christensen R, Wells GA, et al. Biologics for rheumatoid arthritis: an overview of Cochrane reviews. Cochrane Database of Systematic Reviews 2009, Issue 4. Art. No.: CD007848. DOI: 10.1002/14651858. CD007848.pub2. Copyright The Cochrane Collaboration, reproduced with permission.

Pages: 1 2 3 4 | Single Page

Filed Under: Career Development, Conditions, Education & Training, Education & Training, From the College, Professional Topics, Research Reviews, Rheumatoid Arthritis Tagged With: Biologics, Cochrane Library, Cochrane Review, Literature, Research Review, Rheumatoid arthritisIssue: February 2010

You Might Also Like:
  • Anti-TNF Agents May Improve Clinical Symptoms of Ankylosing Spondylitis
  • The ACR Debuts Open Access Journal
  • Patient Fact Sheet: Juvenile Idiopathic Arthritis
  • Dr. Shervin Assassi: New Chair of the ACR Committee on Journal Publications

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)